About Us
We help organizations maximize technology commercial potential and demonstrate value.
ASSESS has been established to re-think how life sciences technology innovators and academic technology transfer offices are supported with early value assessment. ASSESS connects those with expertise in health technology assessment (HTA) and health economic modelling with those that require insights from these disciplines to maximize technology commercial opportunity.
How We Do It
Analytic approach to informing foundational decisions
The goal of ASSESS is that the life sciences ecosystem devotes its energy, expertise and investment to 'Easy Yes' Innovation (EYI) - high-value products that have the evidence for improving patient outcomes and system efficiency that make them attractive investments for payers. This will improve health through promoting investment in the right technologies and the right evidence development, at the right time, to ensure timely patient access.
Early Value Assessment
Health technology assessment (HTA) is often completed to support reimbursement and adoption decision-making, thus relatively late in the R&D cycle. HTAs are completed by trained professionals who advise payers on technology purchase. They provide a comprehensive evaluation of the available evidence of clinical effectiveness, cost-effectiveness, and the ethical, legal, and social implications of health technologies on patient health and the health care system.
ASSESS facilitates early health technology assessment (eHTA), to provide key insights at a time when there is opportunity for innovators to make decisions that support them to focus R&D, commercialization and evidence generation efforts on those that have the highest value from the perspective of the payer and end user.
Health economic modelling
ASSESS facilitates early health economic modelling, to provide key insights on the potential for a technology to be attractive to payers, the value-based price of technology, how effective technology will need to be in order to achieve a desired price, and the relationship between different budget holders in terms of costs and benefits from use of new technology.
Health economic modelling is a quantitative exercise to compare the current standard of care with a potential new standard of care that considers use of the technology in development.
Global reach
ASSESS is a global initiative, supporting innovators, technology transfer offices and working with experts from most major markets. The project utilizes a secure software platform to connect innovators and technology transfer professionals to experts in HTA and health economic modelling.
Why use our global experts?
Expert advice can provide a unique perspective, leveraging years of knowledge and expertise to help you make more informed choices.
On Demand
Our experts are there for you when you need them.
Experience
All our experts are professionals in academia with years of experience.
Disciplines
Our global network spans a wide range of disciplines to service your needs.
50+
Markets of Expertise
60%
> 10 years of experience
70%
MD or PhD Level Education
40+
Disciplines represented
2022
Founded
100+
Global Experts
50+
Markets of Expertise
1 in 2
MD or PhD Level Education
Looking to help shape the health technology landscape?
Contact us to learn more about how insights from ASSESS can help your organization make informed strategic decisions that help maximize commercial success of technology in development.
Let's talk